Adello Biologics LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.adellobio.com
Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2018-07-03
- Lead Sponsor
- Adello Biologics, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT03206229
- Locations
- 🇺🇸
WCCT Global Inc., Cypress, California, United States
Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Adello Biologics, LLC
- Target Recruit Count
- 102
- Registration Number
- NCT03202927
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath